Inside the Business of Commercial Seed Patents

For 10,000 years, farming followed a simple rule: plant a seed, harvest the crop, save the grain, and plant it again. That all changed when biotechnology companies turned plant genetics into patented intellectual property. From the 1930 Plant Patent Act to the landmark Supreme Court ruling in Bowman v. Monsanto, discover how seeds transformed from free biological resources into licensed software protected by utility patents. This video explores the high-stakes economics of agricultural biotechnology, including Roundup Ready soybeans, Bt corn, and the massive upfront R&D costs required to engineer single genetic traits. We break down the business models of agrochemical giants like Bayer, Corteva, Syngenta, and BASF, exploring stewardship agreements, trait licensing fees, detasseling, and the devastating $1.5 billion Syngenta Viptera regulatory misstep. We also examine the hidden vulnerabilities of the seed patent industry—from superweeds like Palmer amaranth evolving resistance to glyphosate, to expired patents, the failed "Terminator" seed technology controversy, and international IP challenges like Basmati rice and Indian cotton regulations. Learn how companies navigate patent cliffs using generic traits and gene-editing tools like CRISPR, and see why the fight over open-source farming is far from over. #FinancialTeardown #uniteconomics #businessmodel #startupcosts #smallbusiness